Grace Therapeutics, Inc. Gain (Loss) on Disposition of Intangible Assets
Grace Therapeutics, Inc. (GRCE) reported Gain (Loss) on Disposition of Intangible Assets of -$39.00 thousand for the 12-month period ending 2024-03-31, per its 10-K filed 2024-06-21.
Discontinued › Income Statement › Other Income
us-gaap:GainLossOnDispositionOfIntangibleAssets · last filed 2024-06-21
- Grace Therapeutics, Inc. gain (loss) on disposition of intangible assets for fiscal 2024 was -$39.00K.
- Grace Therapeutics, Inc. gain (loss) on disposition of intangible assets for fiscal 2023 was -$39.00K.
| Period end | Gain (Loss) on Disposition of Intangible Assets 12 month |
|---|---|
| 2024-03-31 | -$39.00K 10-K · filed 2024-06-21 |
| 2023-03-31 | -$39.00K 10-K · filed 2024-06-21 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PDS Biotechnology Corp (PDSB) | United States | $0.045B | |
| SCYNEXIS INC (SCYX) | United States | $0.045B | |
| Werewolf Therapeutics, Inc. (HOWL) | United States | $0.047B | |
| VERU INC. (VERU) | United States | $0.043B | -3.93 |
| Dogwood Therapeutics, Inc. (DWTX) | United States | $0.049B | |
| Lite Strategy, Inc. (LITS) | United States | $0.049B | |
| Elicio Therapeutics, Inc. (ELTX) | United States | $0.049B | |
| Kairos Pharma, LTD. (KAPA) | United States | $0.041B | |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 | |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |